Insider Transactions in Q4 2020 at Kal Vista Pharmaceuticals, Inc. (KALV)
Insider Transaction List (Q4 2020)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 30
2020
|
Benjamin L Palleiko CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
358
-1.09%
|
$7,160
$20.04 P/Share
|
|
Dec 30
2020
|
Benjamin L Palleiko CHIEF EXECUTIVE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
358
+1.08%
|
$2,148
$6.74 P/Share
|
|
Nov 02
2020
|
Edward P. Feener CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
6,000
-7.62%
|
$102,000
$17.14 P/Share
|
|
Oct 30
2020
|
Albert Cha Director |
BUY
Open market or private purchase
|
Indirect |
115,686
+4.94%
|
$1,966,662
$17.26 P/Share
|
|
Oct 29
2020
|
Thomas Andrew Crockett CEO |
SELL
Bona fide gift
|
Direct |
6,000
-3.24%
|
-
|
|
Oct 29
2020
|
Christopher Yea CHIEF DEVELOPMENT OFFICER |
SELL
Open market or private sale
|
Direct |
5,000
-7.36%
|
$85,000
$17.48 P/Share
|
|
Oct 21
2020
|
Thomas Andrew Crockett CEO |
SELL
Open market or private sale
|
Direct |
22,545
-3.56%
|
$405,810
$18.33 P/Share
|
|
Oct 21
2020
|
Edward P. Feener CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
9,007
-5.26%
|
$162,126
$18.2 P/Share
|
|
Oct 21
2020
|
Christopher Yea CHIEF DEVELOPMENT OFFICER |
SELL
Open market or private sale
|
Direct |
6,044
-4.17%
|
$108,792
$18.35 P/Share
|
|
Oct 20
2020
|
Thomas Andrew Crockett CEO |
SELL
Open market or private sale
|
Direct |
15,994
-3.47%
|
$271,898
$17.64 P/Share
|
|
Oct 20
2020
|
Edward P. Feener CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
7,900
-4.2%
|
$134,300
$17.63 P/Share
|
|
Oct 20
2020
|
Christopher Yea CHIEF DEVELOPMENT OFFICER |
SELL
Open market or private sale
|
Direct |
7,942
-4.95%
|
$135,014
$17.64 P/Share
|
|
Oct 16
2020
|
Edward P. Feener CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
993
-1.03%
|
$16,881
$17.0 P/Share
|
|
Oct 16
2020
|
Christopher Yea CHIEF DEVELOPMENT OFFICER |
SELL
Open market or private sale
|
Direct |
914
-1.1%
|
$15,538
$17.0 P/Share
|
|
Oct 16
2020
|
Thomas Andrew Crockett CEO |
SELL
Open market or private sale
|
Direct |
1,261
-0.53%
|
$21,437
$17.01 P/Share
|